Skip to main content
. 2022 May 30;13:817597. doi: 10.3389/fimmu.2022.817597

Figure 3.

Figure 3

S antibody levels monitored after double vaccination with the Sinopharm vaccine and the Pfizer/BioNtech vaccine booster. (A) S antibody levels of 15 healthy individuals after double Sinopharm vaccination (1st sampling) and subsequent antibody level monitoring (2nd sampling). (B) S antibody levels of 15 healthy individuals after double Sinopharm vaccination (1st sampling) (different individuals from panel A) and after Pfizer/BioNtech booster (2nd sampling). Differences between groups were assessed by Mann Whitney test. The asterisk indicate ***p value < 0.001. ns, not significant.